“…Several conflicting reports exist in which corticosterone is reduced in tumor-bearing models or similar to tumor-free controls at baseline (Bernstein et al, 1985;Bojkova et al, 2011;Mocchegiani et al, 1999;Pyter et al, 2009;Warren et al, 1987;Zepp and Gray, 1983). Also, less corticosterone is bound to plasma carrier proteins in tumor-bearing rats, making it prone to metabolism and poor transport, and therefore, less biologically active (Marc et al, 1974). This may mediate, in part, the observations that tumor-bearing models display elevated baseline corticosterone concentrations, if these studies primarily measure unbound or "free" corticosterone.…”